PATH UIPATH INC

UiPath Helps Mitsubishi Tanabe Pharma Accelerate Business Operational Efficiency

UiPath (NYSE: PATH), a leading software company, today announced that Mitsubishi Tanabe Pharma Corporation, a leading Japanese pharmaceuticals company, has turned to the UiPath Business Automation Platform to improve business operational efficiency that would not have been possible with only human labor.

Mitsubishi Tanabe Pharma aims to create hope for anyone facing an illness. The industry continues to face challenges in developing valuable drugs that truly meet the needs of patients, which makes new drug development more difficult year by year. By introducing UiPath, Mitsubishi Tanabe Pharma is promoting digital technology reform in its new drug development and overall business productivity.

Since implementing UiPath in 2019, Mitsubishi Tanabe Pharma has created more than 500 workflows that automate various tasks. Automation has saved a total of 70,000 hours and has produced significant results in operational efficiency. However, the results are not limited to operational efficiency; it has also enabled several tasks that human labor could have yet to realize.

One such task is to contact prospective employee retirees regarding offboarding procedures. Previously, prospective retirees were contacted once every six months. However, the Human Resources (HR) Department received numerous monthly inquiries from these retirees, which increased the department’s workload. As a result, the HR team now entrusts software robots with the task of contacting retirees every month, which has not only reduced workloads, but has also drastically improved retiree satisfaction.

In the research and development field, they have also developed workflows that add value to its business operations. For example, a workflow was created to crawl academic and society websites, sending an e-mail to the individual in charge when there is updated information. Another workflow extracts necessary information from reports to support the creation of an application form that aggregates many reports prepared by researchers and submits them to the proper medical authorities.

Mitsubishi Tanabe Pharma Provision Corporation (Headquarters: Osaka, Japan; President: Kei Goto) assumed the RPA Center of Excellence, which consolidates all administrative tasks, including pharmaceutical information, accounting, general affairs, and HR for companies under the entire Group into a single point of contact. From the beginning, in anticipation of an era of no-code/low-code development that does not use programming languages, the introduction of the system proceeded on a “self-driven” basis, where on-site employees are encouraged to identify and automate target tasks on their own.

Rob Enslin, Co-Chief Executive Officer, UiPath said, “Today’s automation goes well beyond RPA – it’s the new way of operating and the new way of innovating. To this end, we are pleased to play a key role in Mitsubishi Tanabe Pharma Group’s automation journey by helping them achieve operational efficiency and improve their digital capabilities. By augmenting their automation program with citizen development, Mitsubishi Tanabe Pharma can future-proof their business and build a hybrid human-digital workforce of the future.”

To date, the Center of Excellence has created a unique training program and has encouraged employees to participate actively. The goal is to develop a wide range of citizen developers, including those who can develop workflows and determine which operations are suitable for automation. They have also been developing and operating a new learning curriculum for training advanced developers in cooperation with UiPath. As a next step, the business is planning to further develop this program and its digital human resources, as well as create value-added operations to provide reskilling opportunities for senior personnel.

About UiPath

UiPath has a vision to deliver the Fully Automated Enterprise™, one where companies use automation to unlock their greatest potential. UiPath offers an end-to-end platform for automation, combining the leading Robotic Process Automation (RPA) solution with a full suite of capabilities that enable every organization to rapidly scale digital business operations.

EN
23/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on UIPATH INC

 PRESS RELEASE

UiPath Offers Complimentary Trial of Automation Cloud Public Sector to...

NEW YORK--(BUSINESS WIRE)-- UiPath (NYSE: PATH), a leading software company, today announced a comprehensive designed to help government agencies address operational challenges and drive productivity improvements. Public sector organizations have specific requirements that demand robust, secure, and compliant software solutions. Automation Cloud Public Sector is a cloud-based solution tailored to the specific requirements of public sector organizations in the United States that enables measurable efficiency gains. "In an era of rapidly changing policy mandates and increasing efficiency req...

 PRESS RELEASE

How Agents are Accelerating Enterprise-Wide Transformation: UiPath to ...

NEW YORK--(BUSINESS WIRE)-- UiPath (NYSE: PATH), a leading software company, today announced its annual will take place online on March 25, offering attendees deeper insight into the latest UiPath agentic automation innovations and strategies for implementing agentic AI and automation to deliver consistent, reliable, and transformative business outcomes. Agentic automation integrates AI agents, robots, and people to streamline operations, automate complex end-to-end business processes with multiple workflows and contextual decision-making, improve scalability, and unlock new levels of produ...

 PRESS RELEASE

UiPath Acquires Peak to Launch Vertically Specialized Agents within it...

NEW YORK--(BUSINESS WIRE)-- UiPath (NYSE: PATH), a leading software company, today announced the acquisition of Peak, an AI-native company based in Manchester, United Kingdom. The Peak AI platform optimizes product inventory and pricing for businesses of all sizes and across a wide range of industries, providing customers with tangible outcomes quickly and without the need for large, in-house tech teams. “With the acquisition of Peak, we are accelerating our mission to strengthen our vertical AI solutions strategy,” said Daniel Dines, Founder and CEO of UiPath. “When combined with the UiPath...

 PRESS RELEASE

UiPath Expands Healthcare Automation with New Global Professional Serv...

NEW YORK--(BUSINESS WIRE)-- UiPath (NYSE: PATH), a leading software company, today announced that it has negotiated a new global consulting agreement with a major Electronic Medical Records (EMR) platform to accelerate professional services programs for customers in 16 new countries. With the agreement, UiPath significantly expands its professional services capabilities for healthcare organizations and makes customer and partner access to this EMR platform faster and more seamless. EMRs are the backbone of modern healthcare, connecting patients, providers, and payers with vital information....

 PRESS RELEASE

UiPath to Showcase How Agentic Automation is Transforming the Healthca...

NEW YORK--(BUSINESS WIRE)-- UiPath (NYSE: PATH), a leading software company, today announced it is exhibiting at the in Nashville from February 17-19, 2025 to showcase how agentic automation is empowering healthcare organizations to streamline operations, improve outcomes, and unlock new levels of productivity. The company will exhibit its Agentic Automation capabilities at booth #738. Agentic Automation uses both robots and agents to complete more complex work tasks. The combination of robots and agents extends the capabilities and impact of automation, leading to business growth and empo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch